Eduardo Munoz

Cordoba, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 104 publications

Allosteric Modulation of the CB1 Receptor by a Juniper Berry Seasoning Extract: Deoxypodophyllotoxin as the Major Active Constituent.

Allosteric Modulation of the CB1 Receptor by a Juniper Berry Seasoning Extract: Deoxypodophyllotoxin as the Major Active Constituent.

Journal: Journal of agricultural and food chemistry

Published: February 21, 2026

Cannabidiol improves metabolic profiles and alleviates liver inflammation and fibrosis in conditions of androgenic obesity and polycystic ovary syndrome.

Cannabidiol improves metabolic profiles and alleviates liver inflammation and fibrosis in conditions of androgenic obesity and polycystic ovary syndrome.

Journal: Diabetes, obesity & metabolism

Published: April 22, 2025

Etrinabdione (VCE-004.8), a B55α activator, promotes angiogenesis and arteriogenesis in critical limb ischemia.

Etrinabdione (VCE-004.8), a B55α activator, promotes angiogenesis and arteriogenesis in critical limb ischemia.

Journal: Journal of translational medicine

Published: June 04, 2024

Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy.

Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy.

Journal: Behavioral and brain functions : BBF

Published: May 20, 2024

AMPK Activation by Cimicifuga racemosa Extract Ze 450 Is Associated with Metabolic Effects and Cellular Resilience against Age-Related Pathologies in Different Tissue Cell Types.

AMPK Activation by Cimicifuga racemosa Extract Ze 450 Is Associated with Metabolic Effects and Cellular Resilience against Age-Related Pathologies in Different Tissue Cell Types.

Journal: Pharmaceutics

Published: January 31, 2024

Neuroprotective effects of VCE-004.8 in a rat model of neonatal stroke.

Neuroprotective effects of VCE-004.8 in a rat model of neonatal stroke.

Journal: European journal of pharmacology

Published: December 11, 2023

The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison with The Classic Dopaminergic Replacement Therapy.

The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison with The Classic Dopaminergic Replacement Therapy.

Journal: Brain sciences

Published: July 23, 2023

VCE-005.1, an hypoxia mimetic betulinic acid derivative, induces angiogenesis and shows efficacy in a murine model of traumatic brain injury.

VCE-005.1, an hypoxia mimetic betulinic acid derivative, induces angiogenesis and shows efficacy in a murine model of traumatic brain injury.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 06, 2023

Neuroprotection by the cannabidiol aminoquinone VCE-004.8 in experimental ischemic stroke in mice.

Neuroprotection by the cannabidiol aminoquinone VCE-004.8 in experimental ischemic stroke in mice.

Journal: Neurochemistry international

Published: January 17, 2023

Neuroprotective Effects of Betulinic Acid Hydroxamate in Intraventricular Hemorrhage-Induced Brain Damage in Immature Rats.

Neuroprotective Effects of Betulinic Acid Hydroxamate in Intraventricular Hemorrhage-Induced Brain Damage in Immature Rats.

Journal: Nutrients

Published: November 12, 2022

Minor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research.

Minor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research.

Journal: Biomolecules

Published: July 12, 2022

Cannabidiol markedly alleviates skin and liver fibrosis.

Cannabidiol markedly alleviates skin and liver fibrosis.

Journal: Frontiers in pharmacology

Published: June 29, 2022

Showing 1-12 of 104

Last Updated: 09/26/2026